Loading…

Effect of simvastatin on endothelial function in cardiac syndrome X patients

Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p

Saved in:

Bibliographic Details
Published in:	The American journal of cardiology 2004-09, Vol.94 (5), p.652-655
Main Authors:	Fábián, Emília, Varga, Albert, Picano, Eugenio, Vajo, Zoltan, Rónaszéki, Aladár, Csanády, Miklós
Format:	Article
Language:	English
Subjects:	Aged Anticholesteremic Agents - pharmacology Anticholesteremic Agents - therapeutic use Biological and medical sciences Cardiology Cardiovascular disease Circulatory system Drug therapy Endothelium, Vascular - drug effects Endothelium, Vascular - physiopathology Exercise - physiology Female Humans Hypercholesterolemia - complications Hypercholesterolemia - drug therapy Male Medical sciences Metabolic diseases Microvascular Angina - complications Microvascular Angina - drug therapy Middle Aged Miscellaneous Myocardial Ischemia - complications Myocardial Ischemia - drug therapy Other metabolic disorders Simvastatin - pharmacology Simvastatin - therapeutic use Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3
cites	cdi_FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3
container_end_page	655
container_issue	5
container_start_page	652
container_title	The American journal of cardiology
container_volume	94
creator	Fábián, Emília Varga, Albert Picano, Eugenio Vajo, Zoltan Rónaszéki, Aladár Csanády, Miklós
description	Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p
doi_str_mv	10.1016/j.amjcard.2004.05.035
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66833301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914904008008</els_id><sourcerecordid>66833301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3</originalsourceid><addsrcrecordid>eNqFkVGL1DAQx4Mo3rr6EZQi6FvrpEm6zZPIcd4JC74o-BbmkgmmtM2atAf37c2yhQNffApJfv-ZyS-MveXQcODdp6HBabCYXNMCyAZUA0I9YzveH3TNNRfP2Q4A2lpzqa_Yq5yHsuVcdS_ZFVdCtgLaHTveeE92qaKvcpgeMC-4hLmKc0Wzi8tvGgOOlV9nu4RyWK7OPQPaKj_OLsWJql_VqWRoXvJr9sLjmOnNtu7Zz683P67v6uP322_XX461lbxfaq3lvQOPkpNAQVxh71C2XvXgpNZtD577w0F753nrBTpNWriuswdCKYQTe_bxUveU4p-V8mKmkC2NI84U12y6rhdCAC_g-3_AIa5pLrOZ8nyhtCjgnqkLZFPMOZE3pxQmTI-Ggzm7NoPZXJuzawPKlGzJvduKr_cTuafUJrcAHzYAs8XRJ5xtyE9cB7qTcC70-cJRcfYQKJlsi09LLqTyN8bF8J9R_gL6Bp7y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230359383</pqid></control><display><type>article</type><title>Effect of simvastatin on endothelial function in cardiac syndrome X patients</title><source>Elsevier</source><creator>Fábián, Emília ; Varga, Albert ; Picano, Eugenio ; Vajo, Zoltan ; Rónaszéki, Aladár ; Csanády, Miklós</creator><creatorcontrib>Fábián, Emília ; Varga, Albert ; Picano, Eugenio ; Vajo, Zoltan ; Rónaszéki, Aladár ; Csanády, Miklós</creatorcontrib><description>Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p <0.0001) decrease in total cholesterol, a 38% (p <0.0001) decrease in low-density lipoprotein cholesterol levels, and 7% a (p <0.0001) increase in high-density lipoprotein cholesterol levels, without significant changes in triglyceride levels. Brachial artery flow-mediated dilation increased significantly (52% relative increase, p <0.0001), and the time to >1-mm ST-segment depression during stress testing was longer by the end of the study (p <0.0001).</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2004.05.035</identifier><identifier>PMID: 15342302</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Anticholesteremic Agents - pharmacology ; Anticholesteremic Agents - therapeutic use ; Biological and medical sciences ; Cardiology ; Cardiovascular disease ; Circulatory system ; Drug therapy ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - physiopathology ; Exercise - physiology ; Female ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - drug therapy ; Male ; Medical sciences ; Metabolic diseases ; Microvascular Angina - complications ; Microvascular Angina - drug therapy ; Middle Aged ; Miscellaneous ; Myocardial Ischemia - complications ; Myocardial Ischemia - drug therapy ; Other metabolic disorders ; Simvastatin - pharmacology ; Simvastatin - therapeutic use ; Treatment Outcome</subject><ispartof>The American journal of cardiology, 2004-09, Vol.94 (5), p.652-655</ispartof><rights>2004 Excerpta Medica Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 Excerpta Medica, Inc.</rights><rights>Copyright Elsevier Sequoia S.A. Sep 1, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3</citedby><cites>FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16096405$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15342302$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fábián, Emília</creatorcontrib><creatorcontrib>Varga, Albert</creatorcontrib><creatorcontrib>Picano, Eugenio</creatorcontrib><creatorcontrib>Vajo, Zoltan</creatorcontrib><creatorcontrib>Rónaszéki, Aladár</creatorcontrib><creatorcontrib>Csanády, Miklós</creatorcontrib><title>Effect of simvastatin on endothelial function in cardiac syndrome X patients</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p <0.0001) decrease in total cholesterol, a 38% (p <0.0001) decrease in low-density lipoprotein cholesterol levels, and 7% a (p <0.0001) increase in high-density lipoprotein cholesterol levels, without significant changes in triglyceride levels. Brachial artery flow-mediated dilation increased significantly (52% relative increase, p <0.0001), and the time to >1-mm ST-segment depression during stress testing was longer by the end of the study (p <0.0001).</description><subject>Aged</subject><subject>Anticholesteremic Agents - pharmacology</subject><subject>Anticholesteremic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Circulatory system</subject><subject>Drug therapy</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Exercise - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Hypercholesterolemia - complications</subject><subject>Hypercholesterolemia - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Microvascular Angina - complications</subject><subject>Microvascular Angina - drug therapy</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Myocardial Ischemia - complications</subject><subject>Myocardial Ischemia - drug therapy</subject><subject>Other metabolic disorders</subject><subject>Simvastatin - pharmacology</subject><subject>Simvastatin - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkVGL1DAQx4Mo3rr6EZQi6FvrpEm6zZPIcd4JC74o-BbmkgmmtM2atAf37c2yhQNffApJfv-ZyS-MveXQcODdp6HBabCYXNMCyAZUA0I9YzveH3TNNRfP2Q4A2lpzqa_Yq5yHsuVcdS_ZFVdCtgLaHTveeE92qaKvcpgeMC-4hLmKc0Wzi8tvGgOOlV9nu4RyWK7OPQPaKj_OLsWJql_VqWRoXvJr9sLjmOnNtu7Zz683P67v6uP322_XX461lbxfaq3lvQOPkpNAQVxh71C2XvXgpNZtD577w0F753nrBTpNWriuswdCKYQTe_bxUveU4p-V8mKmkC2NI84U12y6rhdCAC_g-3_AIa5pLrOZ8nyhtCjgnqkLZFPMOZE3pxQmTI-Ggzm7NoPZXJuzawPKlGzJvduKr_cTuafUJrcAHzYAs8XRJ5xtyE9cB7qTcC70-cJRcfYQKJlsi09LLqTyN8bF8J9R_gL6Bp7y</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>Fábián, Emília</creator><creator>Varga, Albert</creator><creator>Picano, Eugenio</creator><creator>Vajo, Zoltan</creator><creator>Rónaszéki, Aladár</creator><creator>Csanády, Miklós</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Effect of simvastatin on endothelial function in cardiac syndrome X patients</title><author>Fábián, Emília ; Varga, Albert ; Picano, Eugenio ; Vajo, Zoltan ; Rónaszéki, Aladár ; Csanády, Miklós</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Anticholesteremic Agents - pharmacology</topic><topic>Anticholesteremic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Circulatory system</topic><topic>Drug therapy</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Exercise - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Hypercholesterolemia - complications</topic><topic>Hypercholesterolemia - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Microvascular Angina - complications</topic><topic>Microvascular Angina - drug therapy</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Myocardial Ischemia - complications</topic><topic>Myocardial Ischemia - drug therapy</topic><topic>Other metabolic disorders</topic><topic>Simvastatin - pharmacology</topic><topic>Simvastatin - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fábián, Emília</creatorcontrib><creatorcontrib>Varga, Albert</creatorcontrib><creatorcontrib>Picano, Eugenio</creatorcontrib><creatorcontrib>Vajo, Zoltan</creatorcontrib><creatorcontrib>Rónaszéki, Aladár</creatorcontrib><creatorcontrib>Csanády, Miklós</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fábián, Emília</au><au>Varga, Albert</au><au>Picano, Eugenio</au><au>Vajo, Zoltan</au><au>Rónaszéki, Aladár</au><au>Csanády, Miklós</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of simvastatin on endothelial function in cardiac syndrome X patients</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>94</volume><issue>5</issue><spage>652</spage><epage>655</epage><pages>652-655</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Patients with cardiac syndrome X with mild hypercholesterolemia were randomized to placebo (n = 20) or simvastatin 20 mg/day (n = 20). In the simvastatin group, there was a significant (26%; p <0.0001) decrease in total cholesterol, a 38% (p <0.0001) decrease in low-density lipoprotein cholesterol levels, and 7% a (p <0.0001) increase in high-density lipoprotein cholesterol levels, without significant changes in triglyceride levels. Brachial artery flow-mediated dilation increased significantly (52% relative increase, p <0.0001), and the time to >1-mm ST-segment depression during stress testing was longer by the end of the study (p <0.0001).</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15342302</pmid><doi>10.1016/j.amjcard.2004.05.035</doi><tpages>4</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0002-9149
ispartof	The American journal of cardiology, 2004-09, Vol.94 (5), p.652-655
issn	0002-9149 1879-1913
language	eng
recordid	cdi_proquest_miscellaneous_66833301
source	Elsevier
subjects	Aged Anticholesteremic Agents - pharmacology Anticholesteremic Agents - therapeutic use Biological and medical sciences Cardiology Cardiovascular disease Circulatory system Drug therapy Endothelium, Vascular - drug effects Endothelium, Vascular - physiopathology Exercise - physiology Female Humans Hypercholesterolemia - complications Hypercholesterolemia - drug therapy Male Medical sciences Metabolic diseases Microvascular Angina - complications Microvascular Angina - drug therapy Middle Aged Miscellaneous Myocardial Ischemia - complications Myocardial Ischemia - drug therapy Other metabolic disorders Simvastatin - pharmacology Simvastatin - therapeutic use Treatment Outcome
title	Effect of simvastatin on endothelial function in cardiac syndrome X patients
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A28%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20simvastatin%20on%20endothelial%20function%20in%20cardiac%20syndrome%20X%20patients&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=F%C3%A1bi%C3%A1n,%20Em%C3%ADlia&rft.date=2004-09-01&rft.volume=94&rft.issue=5&rft.spage=652&rft.epage=655&rft.pages=652-655&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2004.05.035&rft_dat=%3Cproquest_cross%3E66833301%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-994bd0fa41e3a3e15a8da42f580d499280f1f779fdf12f3ad9e93d66c7ea433d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230359383&rft_id=info:pmid/15342302&rfr_iscdi=true